Brainstorm Cell Therapeutics IncEigentümerstruktur
| Preis (2026-07-24) | 52W Hoch | 52W Tief |
| 0.96 USD | 1,69 USD | 0,46 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 17 USD | 0 | 1 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 11.034.775 | 6,46 | 1,27 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Brainstorm Cell Therapeutics Inc
Mitarbeiter 19
Handelsplatz NASDAQ
Ticker Symbol BCLI
IPO Datum 2003-08-28
Adresse 1325 Avenue of Americas, New York, NY, United States, 10019
Webseite https://www.brainstorm-cell.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Chaim Lebovits | President & CEO |
| 2 | Dr. Ibrahim B. Dagher M.D. | Executive VP & Chief Medical Officer |
| 3 | Mr. Uri Yablonka | Executive VP, Chief Business Officer, Secretary & Director |
| 4 | Ms. Alla Patlis CPA, M.B.A. | Interim CFO & Controller |
| 5 | Dr. Hartoun Hartounian Ph.D. | Executive VP & COO |
| 6 | Ms. Mary Kay Turner | Senior Vice President of Patient Advocacy & Government Affairs |
| 7 | Dr. Netta Blondheim-Shraga Ph.D. | Senior Vice President of Research and Development |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BNP Paribas Arbitrage, SA | 0,00% | 0,00 Mio. USD |
| 2 | VSM Wealth Advisory, LLC | 0,00% | 0,00 Mio. USD |
| 3 | Advisor Group Holdings, Inc. | 0,00% | 0,00 Mio. USD |
| 4 | St Germain D J Co Inc | 0,00% | 0,00 Mio. USD |
| 5 | Steward Partners Investment Advisory, LLC | 0,00% | 0,00 Mio. USD |
| 6 | Bangor Savings Bank | 0,00% | 0,00 Mio. USD |